Title : Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease - Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
Author(s) : Fontana RJ , deVries TM , Woolf TF , Knapp MJ , Brown AS , Kaminsky LS , Tang BK , Foster NL , Brown RR , Watkins PB |
Ref : British Journal of Clinical Pharmacology , 46 :221 , 1998 |
Abstract : Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
ESTHER : Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
PubMedSearch : Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
PubMedID: 9764962 |
Title : The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity - Fontana_1996_Hepatology_23_1429 |
Author(s) : Fontana RJ , Turgeon DK , Woolf TF , Knapp MJ , Foster NL , Watkins PB |
Ref : Hepatology , 23 :1429 , 1996 |
Abstract : Fontana_1996_Hepatology_23_1429 |
ESTHER : Fontana_1996_Hepatology_23_1429 |
PubMedSearch : Fontana_1996_Hepatology_23_1429 |
PubMedID: 8675160 |
Title : Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease - Watkins_1994_JAMA_271_992 |
Author(s) : Watkins PB , Zimmerman HJ , Knapp MJ , Gracon SI , Lewis KW |
Ref : Jama , 271 :992 , 1994 |
Abstract : Watkins_1994_JAMA_271_992 |
ESTHER : Watkins_1994_JAMA_271_992 |
PubMedSearch : Watkins_1994_JAMA_271_992 |
PubMedID: 8139084 |